检索结果 - Jin‐Guang Yao

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Recent advances in CD8+ regulatory T�cell research (Review)

    Recent advances in CD8+ regulatory T�cell research (Review) 由 Yating Yu, Xinbo Ma, Rufei Gong, Jianmeng Zhu, Lihua Wei, Jin‐Guang Yao

    出版 2018
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis

    MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis 由 Xiao‐Ying Huang, Jin‐Guang Yao, Hongdong Huang, Chao Wang, Yun Ma, Qiang Xia, Xi‐Dai Long

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis

    MicroRNA-24 Modulates Aflatoxin B1-Related Hepatocellular Carcinoma Prognosis and Tumorigenesis 由 Yixiao Liu, Xi‐Dai Long, Zhifeng Xi, Yun Ma, Xiao‐Ying Huang, Jin‐Guang Yao, Chao Wang, Tianyu Xing, Qiang Xia

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study

    Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled pha... 由 Marianne Pavel, Éric Baudin, Kjell E. Öberg, John D. Hainsworth, Maurizio Voi, Nicolas Rouyrre, Marc Peeters, David J. Gross, Jin‐Guang Yao

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma

    Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma 由 Xi‐Dai Long, Dong Zhao, Chao Wang, Xiao‐Ying Huang, Jin‐Guang Yao, Yun Ma, Zhonghua Wei, Min Liu, Lixiao Zeng, Xiaoqiang Mo, Jianjun Zhang, Feng Xue, Bo Zhai, Qiang Xia

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial

    A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrin... 由 Matthew H. Kulke, Philippe Ruszniewski, Eric Van Cutsem, Catherine Lombard‐Bohas, Juan W. Valle, Wouter W. de Herder, Marianne Pavel, Evgeny Degtyarev, Jan C. Brase, Lida Bubuteishvili‐Pacaud, Maurizio Voi, Ramón Salazar, Ivan Borbath, Nicola Fazio, Denis Smith, Jaume Capdevila, Rachel P. Riechelmann, Jin‐Guang Yao

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: